← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2024-03-05

Drug application

FDA Application #

ANDA207717

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

OXCARBAZEPINE

Active ingredients

OXCARBAZEPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RUBICON RESEARCH

Manufacturer

Advagen Pharma Ltd.

First approval

2024-03-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown